학술논문
508MO Tarlatamab for patients (pts) with previously treated small cell lung cancer (SCLC): Primary analysis of the phase II DeLLphi-301 study.
Document Type
Article
Author
Source
Subject
*SMALL cell lung cancer
Language
ISSN
0923-7534